StaphVax

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2002-2008
01220022008

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
Staphylococcus aureus is an important pathogen in the hospital and in the community, and it is increasingly resistant to multiple… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Review
2008
Review
2008
Staphylococcus aureus, an important bacterial pathogen in the hospital and the community, has become increasingly resistant to… (More)
  • table 1
  • table 2
  • table 3
  • figure 3
  • table 4
Is this relevant?
Review
2006
Review
2006
The pathogenesis of implant-associated infection involves interaction between the microorganisms (biofilm formation), the implant… (More)
Is this relevant?
2004
2004
StaphVAX, an unadjuvanted, bivalent vaccine composed of Staphylococcus aureus (S. aureus) capsular polysaccharides (CPS) types 5… (More)
Is this relevant?
Review
2004
Review
2004
Staphylococcus aureus is the most common nosocomial pathogen and is responsible for approximately one-third of hospital-acquired… (More)
Is this relevant?
Review
2003
Review
2003
  • Drugs in R&D
  • 2003
Staphylococcus aureus is a major cause of hospital-acquired infections and infections in kidney dialysis patients. Over 90% of… (More)
Is this relevant?
Review
2002
Review
2002
StaphVAX is a bivalent polysaccharide- and protein-conjugated vaccine, directed against capsular Staphylococcus aureus types 5… (More)
Is this relevant?